Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-175-VII
HR+
Luminal
Vinorelbine
TUBB
TUBB
7886.042
uM
0.00036
0.14006
-0.9919 -1.0000 0.1845 0.9309
0.7305
0.6462
MDA-MB-175-VII
HR+
Luminal
Vinorelbine
TUBB
TUBB
7884.018
uM
0.01806
0.44303
-0.9591 -1.0000 0.3433 0.7491
0.8263
0.6074
MDA-MB-175-VII
HR+
Luminal
Vorinostat
HDAC
HDAC
7500.065
uM
70.24580
270.90780
-0.9605 -1.0000 0.8139 0.7096
0.9837
0.8201
MDA-MB-175-VII
HR+
Luminal
Vorinostat
HDAC
HDAC
7499.065
uM
33.55520
112.63410
-0.9811 -1.0000 0.9072 0.8235
0.9891
0.5419
MDA-MB-175-VII
HR+
Luminal
XRP44X
ELK3
MAPK
12126.157
uM
1.53120
1.28120
0.2472 0.2949 5.0000 0.3479
0.6402
0.7555
MDA-MB-175-VII
HR+
Luminal
XRP44X
ELK3
MAPK
10818.151
uM
1.0610
0.97420
0.1296 0.1738 5.0000 0.3564
0.9578
0.4459
MDA-MB-175-VII
HR+
Luminal
XRP44X
ELK3
MAPK
10642.139
uM
2.93070
2.40660
0.1064 0.1559 1.8966 0.2717
0.9629
0.7017
MDA-MB-175-VII
HR+
Luminal
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14619.189
uM
0.91694
1.2040
-0.8637 -0.8602 3.6740 0.6116
0.9970
1.2787
MDA-MB-175-VII
HR+
Luminal
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14269.189
uM
0.38947
0.64726
-0.9855 -0.9971 2.1589 0.7210
0.9979
0.5173
MDA-MB-175-VII
HR+
Luminal
ZM-447439
AURK
AURK
10818.15
uM
2.14740
999.68010
0.2751 -0.7643 0.1510 0.3469
0.6844
0.4390
MDA-MB-175-VII
HR+
Luminal
ZM-447439
AURK
AURK
10642.138
uM
19.16960
29.1850
-0.9994 -1.0000 2.6137 0.4105
0.7449
0.5620
MDA-MB-175-VII
HR+
Luminal
ZM-447439
AURK
AURK
12126.16
uM
55.9990
219.56940
0.4954 -0.0915 0.1230 0.3282
0.7819
0.6930
MDA-MB-231
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7892.016
uM
inf
inf
0.9547 0.9547 0.0000 0.0102
0.5298
2.3475
MDA-MB-231
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7893.016
uM
inf
19.83710
0.9104 0.9100 4.9988 -0.0081
0.6344
2.2064
MDA-MB-231
TNBC
Basal B
17-AAG
HSP90
HSP90
7893.05
uM
1.95060
1.91370
-0.0860 0.0152 1.6165 0.2775
0.9811
2.2255
MDA-MB-231
TNBC
Basal B
17-AAG
HSP90
HSP90
7892.037
uM
2.09540
2.01480
-0.0092 0.0346 1.8304 0.2984
0.9940
2.5183
MDA-MB-231
TNBC
Basal B
5-FU
TYMS
TYMS
7892.017
uM
389.45810
1000.00000
-0.0878 -0.3037 0.5033 0.3259
0.9883
2.4495
MDA-MB-231
TNBC
Basal B
5-FU
TYMS
TYMS
7893.017
uM
436.47320
1000.00000
-0.1099 -0.2918 0.5545 0.3222
0.9928
2.2898
MDA-MB-231
TNBC
Basal B
AG1024
IGF1R
RTK
7504.066
uM
38.27430
34.52950
0.6357 0.2000 4.9601 -0.0189
0.8930
1.8487
MDA-MB-231
TNBC
Basal B
AG1478
EGFR
ErbB
7893.016
uM
inf
inf
1.0032 1.0032 0.0000 -0.0097
-0.1970
2.2064
MDA-MB-231
TNBC
Basal B
AG1478
EGFR
ErbB
7892.016
uM
inf
inf
0.9839 0.9839 0.0000 -0.0090
-0.1042
2.3475
MDA-MB-231
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7504.074
uM
0.09433
0.12339
-0.8488 -0.8128 3.5944 0.9992
0.9985
1.8962
MDA-MB-231
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7504.074
uM
0.09433
0.12339
-0.8488 -0.8128 3.5944 0.9992
0.9985
1.8962
MDA-MB-231
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
7892.011
uM
351.20130
453.11770
-0.2505 -0.3681 2.1653 0.1254
0.9974
2.6182
MDA-MB-231
TNBC
Basal B
Cetuximab
EGFR
ErbB
7893.042
uM
inf
inf
0.7448 0.7448 0.0000 0.0660
0.1733
2.2789